Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBITDA: 2019-2024

Historic EBITDA for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$1.16.

  • MDxHealth's EBITDA rose 60.00% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.63, marking a year-over-year increase of 14.86%. This contributed to the annual value of -$1.16 for FY2024, which is 30.12% up from last year.
  • According to the latest figures from FY2024, MDxHealth's EBITDA is -$1.16, which was up 30.12% from -$1.66 recorded in FY2023.
  • In the past 5 years, MDxHealth's EBITDA ranged from a high of -$0.34 in FY2020 and a low of -$2.78 during FY2022.
  • Moreover, its 3-year median value for EBITDA was -$1.66 (2023), whereas its average is -$1.87.
  • As far as peak fluctuations go, MDxHealth's EBITDA skyrocketed by 100.00% in 2020, and later crashed by 600.00% in 2021.
  • MRY analysis of 5 years shows MDxHealth's EBITDA stood at -$0.34 in 2020, then plummeted by 600.00% to -$2.38 in 2021, then dropped by 16.81% to -$2.78 in 2022, then surged by 40.29% to -$1.66 in 2023, then skyrocketed by 30.12% to -$1.16 in 2024.
  • Its EBITDA stands at -$1.16 for FY2024, versus -$1.66 for FY2023 and -$2.78 for FY2022.